Renaissance Technologies LLC Raises Stock Position in Proto Labs, Inc. $PRLB

Renaissance Technologies LLC grew its stake in shares of Proto Labs, Inc. (NYSE:PRLB) by 5.4% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 520,251 shares of the industrial products company’s stock after acquiring an additional 26,700 shares during the period. Renaissance Technologies LLC’s holdings in Proto Labs were worth $29,665,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of PRLB. Disciplined Growth Investors Inc. MN grew its stake in Proto Labs by 1.9% in the second quarter. Disciplined Growth Investors Inc. MN now owns 2,722,011 shares of the industrial products company’s stock worth $108,989,000 after purchasing an additional 51,293 shares in the last quarter. Rubric Capital Management LP raised its position in Proto Labs by 8.6% during the 3rd quarter. Rubric Capital Management LP now owns 1,123,338 shares of the industrial products company’s stock valued at $56,201,000 after purchasing an additional 89,167 shares in the last quarter. American Capital Management Inc. lifted its holdings in shares of Proto Labs by 126.0% in the 4th quarter. American Capital Management Inc. now owns 631,311 shares of the industrial products company’s stock worth $31,938,000 after buying an additional 352,015 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Proto Labs by 0.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 463,780 shares of the industrial products company’s stock worth $26,445,000 after buying an additional 3,162 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Proto Labs by 9.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 363,013 shares of the industrial products company’s stock worth $18,365,000 after buying an additional 31,585 shares in the last quarter. Hedge funds and other institutional investors own 84.54% of the company’s stock.

Proto Labs Trading Down 3.2%

Shares of NYSE PRLB opened at $75.13 on Wednesday. The stock has a market capitalization of $1.79 billion, a PE ratio of 70.88 and a beta of 1.38. The stock’s fifty day simple moving average is $76.82 and its two-hundred day simple moving average is $66.38. Proto Labs, Inc. has a 12-month low of $38.62 and a 12-month high of $83.15.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. The business had revenue of $139.34 million for the quarter, compared to the consensus estimate of $135.31 million. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.The business’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the business posted $0.33 EPS. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. On average, equities analysts predict that Proto Labs, Inc. will post 1.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on PRLB shares. Weiss Ratings upgraded Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, July 17th. Wall Street Zen lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Benchmark increased their target price on shares of Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Finally, Zacks Research downgraded shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 3rd. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $65.33.

Insider Transactions at Proto Labs

In other Proto Labs news, insider Michael R. Kenison sold 16,030 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $69.49, for a total value of $1,113,924.70. Following the completion of the transaction, the insider directly owned 18,683 shares in the company, valued at approximately $1,298,281.67. The trade was a 46.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the sale, the director directly owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 25,663 shares of company stock worth $1,804,727. 1.30% of the stock is owned by corporate insiders.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.